Our Model
We don’t wait for opportunity — we build it. Centralyze combines deep domain expertise, AI-driven discovery, and capital to systematically originate, validate and scale new biomedical ventures
Centralyze.org is an Investment Platform for high-value innovative biotechnologies, addressing an unmet need in global health.
Four key pillars of the Centralyze start-up approach to technology commercialisation are:
ORIGINATE
Using AI (BiblioEngine), we mine global literature and clinical databases to identify under- acknowledged therapeutic opportunities and IP gaps.
DESIGN
We co-develop scientific and regulatory roadmaps with leading researchers, institutions, and clinicians. Our Investor Ready process ensures every asset is capital- ready
BUILD
We form and capitalise new SPVs, assign IP, recruit executive teams, and design proof-of- concept trials in Australia’s globally competitive R&D environment.
SCALE + EXIT
Using early out-licensing, cross-border collaborations, and strategic pharma partner relationships, we deliver capital returns within 4–5 years of company formation.
Services
INVESTMENT
CORPORATE GOVERNANCE
REGULATORY
MEDICAL & GOV AFFAIRS
SALES & MARKETING
MARKET ENTRY
CROSS-BORDER LICENCING
CLINICAL TRIALS
MANUFACTURING
DISTRIBUTION
